Suppressive effects of astaxanthin against rat endotoxin-induced uveitis by inhibiting the NF-kappaB signaling pathway. - Wikidata - awgldk - TriplyDB

Suppressive effects of astaxanthin against rat endotoxin-induced uveitis by inhibiting the NF-kappaB signaling pathway.

Suppressive effects of astaxanthin against rat endotoxin-induced uveitis by inhibiting the NF-kappaB signaling pathway.

http://www.wikidata.org/entity/Q46673133

about

Astaxanthin as a Potential Neuroprotective Agent for Neurological Diseases UVB Stimulates the Expression of Endothelin B Receptor in Human Melanocytes via a Sequential Activation of the p38/MSK1/CREB/MITF Pathway Which Can Be Interrupted by a French Maritime Pine Bark Extract through a Direct Inactivation of MSK1 Protective effect of astaxanthin on liver fibrosis through modulation of TGF-β1 expression and autophagy.Expression of TLR4-MyD88 and NF-κB in the iris during endotoxin-induced uveitis.Prevention of endotoxin-induced uveitis in rats by plant sterol guggulsterone Amelioration of ultraviolet-induced photokeratitis in mice treated with astaxanthin eye drops.Prevention of endotoxin-induced uveitis in rats by benfotiamine, a lipophilic analogue of vitamin B1 Emerging role of antioxidants in the protection of uveitis complications.Treatment with melatonin after onset of experimental uveitis attenuates ocular inflammation.Protective effects of astaxanthin on ConA-induced autoimmune hepatitis by the JNK/p-JNK pathway-mediated inhibition of autophagy and apoptosis.Topical administration of diminazene aceturate decreases inflammation in endotoxin-induced uveitis.Protein kinase Czeta (PKCzeta) regulates ocular inflammation and apoptosis in endotoxin-induced uveitis (EIU): signaling molecules involved in EIU resolution by PKCzeta inhibitor and interleukin-13.The UVB-Stimulated Expression of Transglutaminase 1 Is Mediated Predominantly via the NFκB Signaling Pathway: New Evidence of Its Significant Attenuation through the Specific Interruption of the p38/MSK1/NFκBp65 Ser276 Axis.Astaxanthin Inhibits Expression of Retinal Oxidative Stress and Inflammatory Mediators in Streptozotocin-Induced Diabetic Rats.Efficacy of Astaxanthin for the Treatment of Atopic Dermatitis in a Murine Model Antidiabetic drug metformin suppresses endotoxin-induced uveitis in rats Effects of the immunomodulator, VGX-1027, in endotoxin-induced uveitis in Lewis rats.The effect of astaxanthin on vascular endothelial growth factor (VEGF) levels and peroxidation reactions in the aqueous humor.RETRACTED: Piceatannol suppresses endotoxin-induced ocular inflammation in rats.Astaxanthin: sources, extraction, stability, biological activities and its commercial applications--a review.Amelioration of endotoxin-induced uveitis treated with the sea urchin pigment echinochrome in rats FlexPro MD, a Mixture of Krill Oil, Astaxanthin, and Hyaluronic Acid, Suppresses Lipopolysaccharide-Induced Inflammatory Cytokine Production Through Inhibition of NF-κB.Understanding the role of aldose reductase in ocular inflammation.Microalgae as sources of high added-value compounds--a brief review of recent work.Aldose reductase inhibition prevents endotoxin-induced uveitis in rats.Improvement of accommodation with anti-oxidant supplementation in visual display terminal users.Angiopoietin-like protein 2 mediates endotoxin-induced acute inflammation in the eye.Effects of a novel peptide derived from human thrombomodulin on endotoxin-induced uveitis in vitro and in vivo.The Novel Mechanisms Concerning the Inhibitions of Palmitate-Induced Proinflammatory Factor Releases and Endogenous Cellular Stress with Astaxanthin on MIN6 β-Cells.Protective effects of astaxanthin on skin deterioration.Oral Astaxanthin Supplementation Prevents Peritoneal Fibrosis in Rats.Effect of dietary supplementation of astaxanthin from Phaffia rhodozyma on lipopolysaccharide-induced early inflammatory responses in male broiler chickens (Gallus gallus) fed a corn-enriched diet.Inhibitory effects of oral disulfiram on endotoxin-induced uveitis in rats.Protective Effects of Oral Astaxanthin Nanopowder against Ultraviolet-Induced Photokeratitis in Mice.Astaxanthin Ameliorates Doxorubicin-Induced Cognitive Impairment (Chemobrain) in Experimental Rat Model: Impact on Oxidative, Inflammatory, and Apoptotic Machineries.Effects of a new nutraceutical substance on clinical and molecular parameters in patients with chronic venous ulceration.In vitro and in vivo anti-inflammatory activity of digested peptides derived from salmon myofibrillar protein conjugated with a small quantity of alginate oligosaccharide.Supplementation of xanthophylls decreased proinflammatory and increased anti-inflammatory cytokines in hens and chicks.Astaxanthin attenuates the UVB-induced secretion of prostaglandin E2 and interleukin-8 in human keratinocytes by interrupting MSK1 phosphorylation in a ROS depletion-independent manner.The Evaluation of Astaxanthin Effects on Differentiation of Human Adipose Derived Stem Cells into Oligodendrocyte Precursor Cells.

P2860

Q26785969-DFDF1037-2A25-453E-9E46-2D945988DE10 Q28262690-80B7BC67-87DB-453E-9E39-4A139FE10717 Q33594283-01A79699-FBAD-4C42-BCF0-3A19CAA7E116 Q34089285-CC4A5D78-CCA8-40D0-9587-AFE67498935A Q34161028-BA86A049-C070-4AD9-A32A-89CD1B415AC2 Q34259006-055DFAD9-A6BC-4884-B377-A796E61D2F5C Q34602979-4C8A10B4-E435-48C8-AFC0-9B6DF886162F Q34887046-626AE1B7-5D14-46BA-BEC3-90DEF902234C Q34914207-57300F7B-F78F-448B-96ED-BD92A34768F2 Q35168359-66639131-EBAD-40AC-85FE-DFD20A8DC740 Q35359425-04CBB18D-86C9-43C1-B4D0-E49964112F23 Q35691602-58287038-52EA-4E85-977C-0B0A81BD14A6 Q35754457-0579C5BC-2914-4257-95F3-DB9553DF42C2 Q35893876-E765A967-E0EB-498D-9C05-57CAD6A7C760 Q35972531-BF3DCE7E-33DC-4646-8296-92152BE66645 Q36077002-1C5D4FE8-B060-4217-9BB6-117F16189FB0 Q36977464-525FD9D9-B335-4A8A-94D9-98C1D4C5033C Q37067029-7C900524-4C31-4068-930B-995C12F509B6 Q37205710-3C3E4353-BAC7-423A-AE1A-6CCD7A17B7A1 Q37566186-8E337B9C-29D1-4F90-AB63-60E1522EDC4C Q37574439-EBB17003-58A6-4D3B-BB2A-D5C68CD8DB5D Q37645550-2A373D38-E349-4BBC-A3A3-3DCFACD7AC4F Q37774015-1EB03853-2EBA-4A94-8B0F-0C403DD4BDEC Q37859672-0C5C3495-8A02-44E5-A5E5-DD40A5AE0C8E Q38307889-41C03C08-88FC-4884-9BF8-97319C7B4821 Q38472177-A0D1C682-3BD2-4B9F-9E49-F71E5487EA00 Q39301513-188A9431-1442-4A2A-9C85-25EF6DEB10B9 Q39457809-0B7B2832-7419-4143-A16C-04855D952B50 Q41045868-11E640BC-39F4-4856-A711-2C4DD6C284ED Q41110044-7F9D36EE-16E5-4F13-B94D-D6945E4E1E68 Q41110059-684DB720-BF17-4E3A-9AF1-C93589A3FA51 Q42723616-B3675502-3543-4E3F-8D3A-10240A8D73BD Q42881027-6B61A252-57DB-482D-BE8F-2DC1DA6BAFEF Q43113335-D4A1BC1E-34DD-4026-A561-0C6A55B5CC69 Q48015313-CD2CE551-4E0D-498A-89EA-932DB728CAFC Q48881971-1EFA09B9-9489-49B5-8489-FCDA6FC49DE1 Q53540745-BE19F3B7-7D6B-44CC-BFDE-A1A2C44DFB35 Q54327545-9F94238B-2F8D-4DD5-9768-4CB0A72EB197 Q54508038-A895096B-935E-4500-8283-FEFBEAEFE66A Q55450138-4C8985F8-7D83-4F08-8B58-500144A7A87F

P2860

Suppressive effects of astaxanthin against rat endotoxin-induced uveitis by inhibiting the NF-kappaB signaling pathway.

http://www.wikidata.org/entity/Q46673133

description

2005 nî lūn-bûn

@nan

2005年の論文

@ja

2005年学术文章

@wuu

2005年学术文章

@zh

2005年学术文章

@zh-cn

2005年学术文章

@zh-hans

2005年学术文章

@zh-my

2005年学术文章

@zh-sg

2005年學術文章

@yue

2005年學術文章

@zh-hant

name

Suppressive effects of astaxan ...... e NF-kappaB signaling pathway.

@en

Suppressive effects of astaxan ...... e NF-kappaB signaling pathway.

@nl

type

label

Suppressive effects of astaxan ...... e NF-kappaB signaling pathway.

@en

Suppressive effects of astaxan ...... e NF-kappaB signaling pathway.

@nl

prefLabel

Suppressive effects of astaxan ...... e NF-kappaB signaling pathway.

@en

Suppressive effects of astaxan ...... e NF-kappaB signaling pathway.

@nl

P1433

Q46673133-97CAEACE-E03F-431C-AEEA-DCA08E9CDA07

P1476

Q46673133-471C0E67-90F8-4142-841B-2CC2356F9393

P2093

Q46673133-061CC665-F75C-40DF-A2CF-C9A914D9D219

Q46673133-28943021-AEE1-4E1D-921A-A83D77947C8C

Q46673133-3E9A9432-A53C-44AB-8A58-4F3B3813002E

Q46673133-6DF2B461-A8FF-4F9F-A816-B4E57F8E0B1E

Q46673133-6E0F8809-09C7-4659-B0D2-A4C623CEB505

Q46673133-714D3545-3F25-4660-ADBF-B2300E957E79

Q46673133-7E8D250C-6D0F-4D6F-B443-E6707D3825EC

Q46673133-9F4626BE-C8BF-4177-9053-3183B452C9D6

Q46673133-C0348100-1082-4E1D-BD89-BCC42FD9EB76

Q46673133-FB036349-A189-4FD4-9CEB-21F462E39090

P304

Q46673133-F1E41AFE-BB40-47D5-A94C-0C8F85E63F32

P31

Q46673133-A6F97BA2-11C7-4B19-9DAC-D99EF199DAC1

P356

Q46673133-BC5AA00E-72DA-4524-90B3-0C3B84171209

P433

Q46673133-84FE83A2-F604-4DFD-BA86-D59E5CE707FC

P478

Q46673133-CE3CEDA9-948C-4FDD-AC36-F3652C06D516

P577

Q46673133-CDBDB421-24C0-41E6-A08D-F64A15A7FEDC

P5875

Q46673133-477B527F-B1D2-4A52-B0C4-E1B7982D005B

P698

Q46673133-351D8341-180B-4D04-B4E0-DF7915F559FB

P921

Q46673133-02BAB7CE-5744-4D08-95BC-6ABC92351134

Q46673133-8486711E-6852-4FEB-A8EB-EA3C45DFD6DF

Q46673133-B2D99F3C-470E-4D54-B324-C0E8A3F6311E

Q46673133-F8BFED03-2F90-48BC-B42C-636CB2517C0C

P356

J.EXER.2005.06.023

P1433

Experimental Eye Research

P1476

Suppressive effects of astaxan ...... e NF-kappaB signaling pathway.

@en

P2093

Iliyana Ilieva

http://www.w3.org/2001/XMLSchema#string

Kazuhiko Yoshida

http://www.w3.org/2001/XMLSchema#string

Kazuhiro Ohgami

http://www.w3.org/2001/XMLSchema#string

Kazunaga Yazawa

http://www.w3.org/2001/XMLSchema#string

Kenji Shiratori

http://www.w3.org/2001/XMLSchema#string

Satoru Kase

http://www.w3.org/2001/XMLSchema#string

Shigeaki Ohno

http://www.w3.org/2001/XMLSchema#string

Xue-Hai Jin

http://www.w3.org/2001/XMLSchema#string

Yoshikazu Koyama

http://www.w3.org/2001/XMLSchema#string

Yukari Suzuki

http://www.w3.org/2001/XMLSchema#string

P304

275-281

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.EXER.2005.06.023

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

82

http://www.w3.org/2001/XMLSchema#string

P577

2005-08-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7634985

http://www.w3.org/2001/XMLSchema#string

P698

16126197

http://www.w3.org/2001/XMLSchema#string

P921